InvestSMART

Oncosil Medical Limited (ASX: OSL) - Announcements

Current share price for OSL : $0.715 0.035 (4.67%)+

ASX company news and announcements for Oncosil Medical Limited (OSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Oncosil Medical Limited (OSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Oncosil Medical Limited (OSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Oncosil Medical Limited (OSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$26 Quarterly Activities/Appendix 4C Cash Flow Report 28 Apr 2026 9:33AM $0.485 $0.715 risen by 47.42%
$26 Change of Share Registry Details 10 Apr 2026 9:46AM $0.515 $0.715 risen by 38.83%
$26 OSPREY Registry Data Accepted for Presentation at ESGE Days 8 Apr 2026 9:29AM $0.500 $0.715 risen by 43%
$26 Change in substantial holding from SOL 20 Mar 2026 7:21PM $0.485 $0.715 risen by 47.42%
$26 Becoming a substantial holder 19 Mar 2026 4:57PM $0.475 $0.715 risen by 50.53%
$26 Change in substantial holding from PCG 19 Mar 2026 1:40PM $0.465 $0.715 risen by 53.76%
$26 Change of Director's Interest Notice X2 19 Mar 2026 11:08AM $0.500 $0.715 risen by 43%
$26 Late Lodgement of Appendix 3Y 19 Mar 2026 11:07AM $0.500 $0.715 risen by 43%
$26 Security Class Reinstatement to Quotation - OSLOE 18 Mar 2026 8:49AM $0.550 $0.715 risen by 30%
$26 Notice Under Section 708A 17 Mar 2026 12:03PM $0.500 $0.715 risen by 43%
$26 Top 20 Holders and Range of Units for Attaching Options 17 Mar 2026 12:01PM $0.500 $0.715 risen by 43%
$26 Application for quotation of securities - OSL 17 Mar 2026 11:55AM $0.515 $0.715 risen by 38.83%
$26 Application for quotation of securities - OSL 17 Mar 2026 11:44AM $0.515 $0.715 risen by 38.83%
$26 Application for quotation of securities - OSL 17 Mar 2026 11:40AM $0.515 $0.715 risen by 38.83%
$26 Application for quotation of securities - OSL 17 Mar 2026 11:40AM $0.515 $0.715 risen by 38.83%
$26 Results of Entitlement Offer 17 Mar 2026 8:51AM $0.550 $0.715 risen by 30%
$26 Results of Meeting 12 Mar 2026 11:46AM $0.570 $0.715 risen by 25.44%
$26 Security Class Suspension from Quotation 11 Mar 2026 9:20AM $0.595 $0.715 risen by 20.17%
$26 Appendix 4D and Half Year Accounts 24 Feb 2026 9:33AM $0.650 $0.715 risen by 10%
$26 Ceasing to be a substantial holder 13 Feb 2026 4:51PM $0.680 $0.715 risen by 5.15%
$26 Notice of Extraordinary General Meeting/Proxy Form 12 Feb 2026 9:37AM $0.700 $0.715 risen by 2.14%
$26 Proposed issue of securities - OSL 12 Feb 2026 9:17AM $0.700 $0.715 risen by 2.14%
$26 CEO Remuneration Update 12 Feb 2026 9:17AM $0.700 $0.715 risen by 2.14%
$26 Becoming a substantial holder 11 Feb 2026 5:41PM $0.700 $0.715 risen by 2.14%
$26 Entitlement Offer Opens 11 Feb 2026 12:04PM $0.720 $0.715 fallen by 0.69%

51 - 75 of 812 results

Page 3 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.